We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CLPBF market cap is 26.89B. The company's latest EPS is DKK 22.7545 and P/E is 5.29.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 17.94B | 18.54B | 19.43B | 22.58B | 24.5B |
| Operating Income | 5.16B | 5.85B | 6.16B | 6.44B | 6.77B |
| Net Income | 3.87B | 4.2B | 4.83B | 4.71B | 4.78B |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 12.73B | 13.5B | 15.84B | 34.96B | 48.16B |
| Total Liabilities | 5.82B | 6.09B | 7.67B | 26.66B | 30.86B |
| Total Equity | 6.91B | 7.41B | 8.17B | 8.29B | 17.3B |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 4.36B | 4.76B | 5.29B | 5.1B | 4.23B |
| Investing | -591M | -901M | -2.01B | -11.76B | -8.96B |
| Financing | -3.71B | -3.86B | -3.18B | 6.59B | 5.27B |
| Market Cap | 26.89B |
| Price to Earnings Ratio | 5.29 |
| Price to Sales Ratio | 1.03 |
| Price to Cash Ratio | 27.76 |
| Price to Book Ratio | 1.46 |
| Dividend Yield | - |
| Shares Outstanding | 210.2M |
| Average Volume (1 week) | 321 |
| Average Volume (1 Month) | 365 |
| 52 Week Change | -11.02% |
| 52 Week High | 145.05 |
| 52 Week Low | 99.7762 |
| Spread (Intraday) | 54.04k (99.84%) |
| Company Name | Coloplast AS (PK) |
| Address |
holtedam 1-3 humlebaek DK-3050 |
| Website | https://www.coloplast.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
